Wendell Amy McBride
Director at AXGN; Senior Vice President at Covidien Ltd.
- Sold, on record
- $17.3M
- Dollars the filings state
- Form 4 sales
- 16
- Latest Aug 11, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- AXGNAxogen, Inc.Director
- Covidien Ltd.Senior Vice President
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Covidien Ltd.250,421 shares
- AXGN67,757 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Covidien Ltd.UnusualNov 12 2013
Sold 17,209 shares at $64.31 ($1.1M)
Wendell Amy McBride, Senior Vice President
Sold 32% of holdings ($3.5M position)36,626 shares left1.1x usual sizeFiling
- 2 Form 4 sale Covidien Ltd.UnusualNov 14 +2 days
Sold 14,000 shares at $66.00 ($924k)
Wendell Amy McBride, Senior Vice President
Sold 27.7% of holdings ($3.3M position)36,626 shares left0.9x usual sizeFiling
- 3 Form 4 sale Covidien Ltd.UnusualNov 26 +12 days
Sold 14,000 shares at $68.00 ($952k)
Wendell Amy McBride, Senior Vice President
Sold 27.7% of holdings ($3.4M position)36,626 shares left0.9x usual sizeFiling
- 4 Form 4 sale AXGNNo planMar 3 +4115 days
Sold 5,000 shares at $20.02 ($100k)
Wendell Amy McBride, Director
No 10b5-1 planSold 4.9% of holdings ($2.1M position)97,899 shares leftFirst sale on recordFiling
- 5 Form 4 sale AXGNNo planJun 9 +98 days
Sold 4,073 shares at $10.61 ($43k)
Wendell Amy McBride, Director
No 10b5-1 planSold 4.2% of holdings ($1M position)93,826 shares leftFiling
- 6 Form 4 sale AXGNUnusualDec 16 +190 days
Sold 43,684 shares at $29.31 ($1.3M)
Wendell Amy McBride, Director
No 10b5-1 planSold 31.8% of holdings ($4M position)93,826 shares leftFiling
- 7 Form 4 sale AXGNNo planMay 8 +143 days
Sold 1,647 shares at $42.60 ($70k)
Wendell Amy McBride, Director
No 10b5-1 planSold 1.7% of holdings ($4.1M position)93,826 shares left0.3x usual sizeFiling
- 8 Form 4 sale AXGNRoutineAug 11 +95 days
Sold 13,353 shares at $48.42 ($647k)
Wendell Amy McBride, Director
10b5-1 planSold 11% of holdings ($5.9M position)107,976 shares left2.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (16)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | AXGN | Director | Form 4 sale | 13,353 | $647k | 11.0% | Routine | SEC |
| May 8, 2026 | AXGN | Director | Form 4 sale | 1,647 | $70k | 1.7% | No plan | SEC |
| Dec 16, 2025 | AXGN | Director | Form 4 sale | 43,684 | $1.3M | 31.8% | Unusual | SEC |
| Jun 9, 2025 | AXGN | Director | Form 4 sale | 4,073 | $43k | 4.2% | No plan | SEC |
| Mar 3, 2025 | AXGN | Director | Form 4 sale | 5,000 | $100k | 4.9% | No plan | SEC |
| Nov 26, 2013 | Covidien Ltd. | Senior Vice President | Form 4 sale | 14,000 | $952k | 27.7% | Unusual | SEC |
| Nov 14, 2013 | Covidien Ltd. | Senior Vice President | Form 4 sale | 14,000 | $924k | 27.7% | Unusual | SEC |
| Nov 12, 2013 | Covidien Ltd. | Senior Vice President | Form 4 sale | 17,209 | $1.1M | 32.0% | Unusual | SEC |
| Aug 8, 2013 | Covidien Ltd. | Senior Vice President | Form 4 sale | 25,081 | $1.6M | 36.2% | Unusual | SEC |
| Apr 2, 2013 | Covidien Ltd. | Senior Vice President | Form 4 sale | 18,031 | $1.2M | 26.2% | Unusual | SEC |
| Mar 13, 2013 | Covidien Ltd. | Senior Vice President | Form 4 sale | 15,000 | $990k | 22.8% | Plan not stated | SEC |
| Mar 4, 2013 | Covidien Ltd. | Senior Vice President | Form 4 sale | 15,000 | $960k | 22.8% | Plan not stated | SEC |
| Jan 25, 2013 | Covidien Ltd. | Senior Vice President | Form 4 sale | 15,000 | $953k | 22.8% | Plan not stated | SEC |
| May 4, 2012 | Covidien Ltd. | Senior Vice President | Form 4 sale | 10,166 | $554k | 19.5% | Plan not stated | SEC |
| Apr 28, 2011 | Covidien Ltd. | Senior Vice President | Form 4 sale | 84,983 | $4.8M | 64.9% | Unusual | SEC |
| Feb 4, 2010 | Covidien Ltd. | Senior Vice President | Form 4 sale | 21,951 | $1.1M | 32.7% | Unusual | SEC |